Hanover - Delayed Quote EUR
Sartorius Stedim Biotech SA (56S1.HA)
205.50
+1.60
+(0.78%)
At close: April 30 at 5:25:25 PM GMT+2
Loading Chart for 56S1.HA
- Previous Close
203.90 - Open
204.60 - Bid 206.10 x --
- Ask 206.80 x --
- Day's Range
204.50 - 207.50 - 52 Week Range
145.30 - 227.70 - Volume
52 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Jul 22, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 56S1.HA
View MorePerformance Overview: 56S1.HA
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .
YTD Return
56S1.HA
11.05%
CAC 40 (^FCHI)
2.89%
1-Year Return
56S1.HA
1.73%
CAC 40 (^FCHI)
4.90%
3-Year Return
56S1.HA
33.24%
CAC 40 (^FCHI)
16.22%
5-Year Return
56S1.HA
41.98%
CAC 40 (^FCHI)
66.09%
Compare To: 56S1.HA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
205.50
+0.78%
Mkt Cap EUR -
Industry Medical Instruments & Supplies
185.40
-0.22%
Mkt Cap EUR 14.251B
Industry Medical Instruments & Supplies
60.10
+1.01%
Mkt Cap EUR 5.261B
Industry Medical Instruments & Supplies
Statistics: 56S1.HA
View MoreValuation Measures
As of 4/30/2025
Market Cap
20.06B
Enterprise Value
22.27B
Trailing P/E
97.39
Forward P/E
46.73
PEG Ratio (5yr expected)
3.10
Price/Sales (ttm)
6.96
Price/Book (mrq)
5.03
Enterprise Value/Revenue
7.79
Enterprise Value/EBITDA
30.48
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--